Zusammenfassung
Es existiert laut Literatur eine Vielzahl von potenziellen systemischen Kontraindikationen für korneal refraktiv-chirurgische Verfahren. In Fällen mit relativen Kontraindikationen darf der Eingriff nur unter Abwägung der individuellen Risiken und unter stabilen Krankheitsbedingungen erfolgen. Die „Evidenz“ vieler dieser Kontraindikationen basiert aber nur auf Fallberichten oder -serien, Expertenmeinungen oder bekannten Komplikationen bei nicht lasergestützten Augenoperationen. Randomisierte klinische Studien sind daher erforderlich.
Abstract
According to the literature there are a large number of potential systemic contraindications for corneal refractive surgery. In cases with relative contraindications, surgery should be performed only after weighing up the individual risks and under controlled disease conditions; however, the “evidence” for many of these contraindications is based only on case reports or series, expert opinions or known complications in non-laser-assisted eye surgery. Randomized clinical trials are therefore required.
Literatur
Alió JL, Artola A, Belda JI, Perez-Santonja JJ, Muñoz G, Javaloy J, Rodríguez-Prats JL, Galal A (2005) LASIK in patients with rheumatic diseases. A pilot study. Ophthalmology 112:1948–1954
Aman-Ullah M, Gimbel HV, Purba MK, van Westenbrugge JA (2012) Necrotizing keratitis after laser refractive surgery in patients with inactive inflammatory bowel disease. Case Rep Ophthalmol 3:54–60
Artola A, Gala A, Belda JI, Pérez-Santonja JJ, Rodriguez-Prats JL, Ruiz-Moreno JM, Alió JL (2006) LASIK in myopic patients with dermatological keloids. J Refract Surg 22:505–508
Bower KS, Woreta F (2014) Update on contraindications for laser-assisted in situ keratomileusis and photorefractive keratectomy. Curr Opin Ophthalmol 25:251–257
Cobo-Soriano R, Beltran J, Baviera J (2006) LASIK outcomes in patients with underlying systemic contraindications. A preliminary study. Ophthalmology 113:1118–1124
Conroy MA, Duran PA, Avery JD (2016) A Case of New-Onset Psychosis Following Laser In Situ Keratomileusis (LASIK) Eye Surgery. Prim Care Companion Cns Disord 22:18
Cua IY, Pepose JS (2002) Late corneal scarring after photorefractive keratectomy concurrent with development of systemic lupus erythematosus. J Refract Surg 18:750–752
O’Doherty MA, O’Doherty JV, O’Keefe M (2006) Outcome of LASIK for myopia in women on hormone replacement therapy. J Refract Surg 22:350–353
Engelhard SB, Shah CT, Sim AJ, Reddy AK (2018) Malpractice Litigation in Cornea and Refractive Surgery: A Review of the WestLaw Database. Cornea 37:537–541
Fraunfelder FW, Rich LF (2002) Laser-assisted in situ keratomileusis complications in diabetes mellitus. Cornea 21:246–248
Ghaffariyeh A, Chamacham T (2008) Tricyclic antidepressants: potential therapeutic alternatives for treatment of dry eye symptoms after LASIK. J Refract Surg 24:770–771
Girgis R, Morris DS, Kotagiri A, Ramaesh K (2007) Bilateral corneal scarring after LASIK and PRK in a patient with propensity to keloid scar formation. Eye (Lond) 21:96–97
Gotovac M, Kastelan S, Lukenda A (2013) Eye and pregnancy. Coll Antropol 37:189–193
Hagen KB, Kettering JD, Aprecio RM, Beltran F, Maloney RK (1997) Lack of virus transmission by the excimer laser plume. Am J Ophthalmol 124:206–211
Halkiadakis I, Belfair N, Gimbel HV (2005) Laser in situ keratomileusis in patients with diabetes. J Cataract Refract Surg 31:1895–1898
Hardten DR, Hira NK, Lombardo AJ (2005) Triptans and the incidence of epithelial defects during laser in situ keratomileusis. J Refract Surg 21:72–76
Hovanesian JA, Faktorovich EG, Hoffbauer JD, Shah SS, Maloney RK (1999) Bilateral bacterial keratitis after laser in situ keratomileusis in a patient with human immunodeficiency virus infection. Arch Ophthalmol 117:968–970
Karalezli A, Borazan M, Altinors DD, Dursun R, Kiyici H, Akova YA (2009) Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin. Cornea 28:46–50
Lahners WJ, Hardten DR, Lindstrom RL (2003) Peripheral keratitis following laser in situ keratomileusis. J Refract Surg 19:671–675
Lee JY, Youm DJ, Choi CY (2011) Conventional Epi-LASIK and lamellar epithelial debridement in myopic patients with dermatologic keloids. Korean J Ophthalmol 25:206–209
Liang L, Zhang M, Zou W, Liu Z (2008) Aggravated dry eye after laser in situ keratomileusis in patients with Sjogren syndrome. Cornea 27:120–123
Long Q, Chu R, Zhou X, Dai J, Chen C, Rao SK, Lam DS (2006) Correlation between TGF-beta1 in tears and corneal haze following LASEK and epi-LASIK. J Refract Surg 22:708–712
Mackensen F, Paulus WE, Max R, Ness T (2014) Ocular changes during pregnancy. Dtsch Arztebl Int 111:567–575
Malik M, Simpson RC, Varma S (2011) Isotretinoin as contraindication. BMJ 342:d3353
Mirshahi A, Kohnen T (2003) Acute psychotic reaction caused by topical cyclopentolate use for cycloplegic refraction before refractive surgery: case report and review of the literature. J Cataract Refract Surg 29:1026–1030
Moon SJ, Mann PM, Matoba AY (2003) Microsporidial keratoconjunctivitis in a healthy patient with a history of LASIK surgery. Cornea 22:271–272
Morse JS, Schallhorn SC, Hettinger K, Tanzer D (2009) Role of depressive symptoms in patient satisfaction with visual quality after laser in situ keratomileusis. J Cataract Refract Surg 35:341–346
Ortega-Usobiaga J, García-Sáenz MC, Artaloytia-Usobiaga JF, Llovet-Osuna F, Beltrán-Sanz J, Baviera-Sabater J (2012) Myopic LASIK in psychiatric patients. Cornea 31:150–154
Simpson RG, Moshirfar M, Edmonds JN, Christiansen SM (2012) Laser in-situ keratomileusis in patients with diabetes mellitus: a review of the literature. Clin Ophthalmol 6:1665–1674
Smith RJ, Maloney RK (2006) LASIK in patients with autoimmune diseases. J Cataract Refract Surg 32:1292–1295
Spadea L, Paroli MP (2012) Laser refractive surgery in diabetic patients: a review of the literature. Clin Ophthalmol 6:1775–1783
Tanzer DJ, Isfahani A, Schallhorn SC, LaBree LD, McDonnell PJ (1998) Photorefractive keratectomy in African Americans including those with known dermatologic keloid formation. Am J Ophthalmol 126:625–629
Förderung
Diese Arbeit wurde von der Ernst- und Berta-Grimmke-Stiftung gefördert.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A. Frings, N. Ardjomand, T. Katz, S.J. Linke und J. Steinberg geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Frings, A., Ardjomand, N., Katz, T. et al. Refraktive Hornhautchirurgie trotz systemischer Erkrankungen?. Ophthalmologe 116, 677–681 (2019). https://doi.org/10.1007/s00347-019-0852-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-019-0852-z